{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Cervical cancer",
      "C\u00e1ncer cervical",
      "Human papillomavirus",
      "Lesiones precancerosas",
      "Nonavalent vaccine",
      "Pre-cancerous lesions",
      "Vacuna nonavalente",
      "Virus del papiloma humano"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28549940",
  "DateCompleted": {
    "Year": "2018",
    "Month": "03",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "05",
        "Day": "23"
      }
    ],
    "Language": [
      "spa"
    ],
    "ELocationID": [
      "10.1016/j.semerg.2017.04.010",
      "S1138-3593(17)30116-8"
    ],
    "Journal": {
      "ISSN": "1578-8865",
      "JournalIssue": {
        "Volume": "43",
        "Issue": "4",
        "PubDate": {
          "Year": "2017",
          "Season": "May-Jun"
        }
      },
      "Title": "Semergen",
      "ISOAbbreviation": "Semergen"
    },
    "ArticleTitle": "[Human papillomavirus nonavalent vaccine. Update 2017].",
    "Pagination": {
      "StartPage": "265",
      "EndPage": "276",
      "MedlinePgn": "265-276"
    },
    "Abstract": {
      "AbstractText": [
        "Human papillomavirus (HPV) is the causative agent of 5% of human cancers. HPV infection is necessary for the development of cervical cancer and is responsible of a variable percentage of cancers of anus, vulva, vagina, penis, and oropharynx. Since 2007, 2 vaccines against HPV have been commercially available in Spain: bivalent (HPV types 16/18), and tetravalent (HPV types 6/11/16/18). In order to extend the protection afforded by HPV vaccines, a clinical program was launched in 2006 for the new nonavalent vaccine, including 9 HPV types (6/11/16/18/31/33/45/52/58). These types are responsible for 90% of cervical cancers, 82% of high-grade ano-genital pre-cancerous lesions, and 90% of genital warts. The purpose of this publication is to provide healthcare professionals with the scientific evidence that supports the new vaccine, as well as the clinical value that it offers in our environment."
      ],
      "CopyrightInformation": "Copyright \u00a9 2017 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Publicado por Elsevier Espa\u00f1a, S.L.U. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Servicio de Epidemiolog\u00eda del C\u00e1ncer, Institut Catal\u00e0 d'Oncologia (ICO), Barcelona, Espa\u00f1a; Programa de Recerca en Epidemiologia del C\u00e0ncer, Institut Catal\u00e0 d'Oncologia, Hospitalet de Llobregat, Barcelona, Espa\u00f1a. Electronic address: xbosch.ico@gmail.com."
          }
        ],
        "LastName": "Bosch",
        "ForeName": "F X",
        "Initials": "FX"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Secci\u00f3n de Infectolog\u00eda e Inmunodeficiencias, UGC Pediatr\u00eda, Hospital Materno-Infantil, Complejo Regional Universitario de M\u00e1laga, M\u00e1laga, Espa\u00f1a; Departamento de Pediatr\u00eda, Facultad de Medicina, Universidad de M\u00e1laga, Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Espa\u00f1a."
          }
        ],
        "LastName": "Moreno",
        "ForeName": "D",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centro de Salud Internacional, Madrid Salud, Ayuntamiento de Madrid, Madrid, Espa\u00f1a; Grupo de Actividades Preventivas y Salud P\u00fablica de la Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN), Madrid, Espa\u00f1a."
          }
        ],
        "LastName": "Redondo",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidad de Ginecolog\u00eda Oncol\u00f3gica, Instituto Cl\u00ednico de Ginecolog\u00eda y Obstetricia y Neonatolog\u00eda (ICGON), Hospital Cl\u00ednic, Barcelona, Espa\u00f1a; Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS), Facultad de Medicina, Universidad de Barcelona, Barcelona, Espa\u00f1a."
          }
        ],
        "LastName": "Torn\u00e9",
        "ForeName": "A",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ],
    "VernacularTitle": "Vacuna nonavalente frente al virus del papiloma humano. Actualizaci\u00f3n 2017."
  },
  "MedlineJournalInfo": {
    "Country": "Spain",
    "MedlineTA": "Semergen",
    "NlmUniqueID": "9610769",
    "ISSNLinking": "1138-3593"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Papillomavirus Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Drug Approval"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pathology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Papillomaviridae"
    },
    {
      "QualifierName": [
        "complications",
        "prevention & control"
      ],
      "DescriptorName": "Papillomavirus Infections"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Papillomavirus Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Spain"
    },
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Uterine Cervical Neoplasms"
    }
  ]
}